Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Editorial Comment

被引：0
|
作者：
Marshall, Fray F.
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 184卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1303 / 1303
页数：1
相关论文
共 50 条
  • [11] Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma
    Hutson, T. E.
    Bukowski, R. M.
    Rini, B. I.
    Gore, M. E.
    Larkin, J. M.
    Figlin, R. A.
    Barrios, C. H.
    Escudier, B.
    Lin, X.
    Fly, K.
    Martell, B.
    Matczak, E.
    Motzer, R. J.
    BRITISH JOURNAL OF CANCER, 2014, 110 (05) : 1125 - 1132
  • [12] Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma
    T E Hutson
    R M Bukowski
    B I Rini
    M E Gore
    J M Larkin
    R A Figlin
    C H Barrios
    B Escudier
    X Lin
    K Fly
    B Martell
    E Matczak
    R J Motzer
    British Journal of Cancer, 2014, 110 : 1125 - 1132
  • [13] Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma
    Kim, Ki Hyang
    Yoon, Sang Hyun
    Lee, Hae-Jung
    Kim, Hyo Song
    Shin, Sang Joon
    Ahn, Joong Bae
    Rha, Sun Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (04) : 853 - 860
  • [14] Efficacy and safety of axitinib in elderly patients with metastatic renal cell carcinoma
    Hideaki Miyake
    Ken-ichi Harada
    Seiichiro Ozono
    Masato Fujisawa
    Medical Oncology, 2016, 33
  • [15] Pazopanib for the Treatment of Metastatic Renal Cell Carcinoma
    Pick, Amy M.
    Nystrom, Kelly K.
    CLINICAL THERAPEUTICS, 2012, 34 (03) : 511 - 520
  • [16] Editorial Comment to Efficacy and safety of first-line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study
    Tamada, Satoshi
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (12) : 1100 - 1101
  • [17] Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma
    A B Suttle
    H A Ball
    M Molimard
    T E Hutson
    C Carpenter
    D Rajagopalan
    Y Lin
    S Swann
    R Amado
    L Pandite
    British Journal of Cancer, 2014, 111 : 1909 - 1916
  • [18] Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma
    Suttle, A. B.
    Ball, H. A.
    Molimard, M.
    Hutson, T. E.
    Carpenter, C.
    Rajagopalan, D.
    Lin, Y.
    Swann, S.
    Amado, R.
    Pandite, L.
    BRITISH JOURNAL OF CANCER, 2014, 111 (10) : 1909 - 1916
  • [19] Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study
    Amin, Asim
    Plimack, Elizabeth R.
    Ernstoff, Marc S.
    Lewis, Lionel D.
    Bauer, Todd M.
    McDermott, David F.
    Carducci, Michael
    Kollmannsberger, Christian
    Rini, Brian I.
    Heng, Daniel Y. C.
    Knox, Jennifer
    Voss, Martin H.
    Spratlin, Jennifer
    Berghorn, Elmer
    Yang, Lingfeng
    Hammers, Hans J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [20] Pazopanib after sunitinib failure in patients with metastatic renal cell carcinoma
    Rautiola, Juhana
    Utriainen, Tapio
    Peltola, Katriina
    Joensuu, Heikki
    Bono, Petri
    ACTA ONCOLOGICA, 2014, 53 (01) : 113 - 118
12345